Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$872M |
| 2 |
Microsoft
MSFT
|
$324M |
| 3 |
Intuit
INTU
|
$313M |
| 4 |
PTC
PTC
|
$289M |
| 5 |
Amazon
AMZN
|
$286M |
Top Sells
| 1 |
Linde
LIN
|
$575M |
| 2 |
Booking.com
BKNG
|
$570M |
| 3 |
Meta Platforms (Facebook)
META
|
$538M |
| 4 |
NVIDIA
NVDA
|
$455M |
| 5 |
Salesforce
CRM
|
$401M |
Sector Composition
| 1 | Technology | 32.54% |
| 2 | Healthcare | 19.02% |
| 3 | Financials | 11.15% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Enpro
NPO
$4.58B
| $27M | 0.01% |
165,145
-21,246
| -11% | -$3.47M |
|
502
Towne Bank
TOWN
$2.87B
| $26.9M | 0.01% |
780,008
-7,659
| -1% | -$264K |
|
503
Zimmer Biomet
ZBH
$20.9B
| $26.7M | 0.01% |
237,619
+79,786
| +51% | +$8.96M |
|
504
Novo Nordisk
NVO
$245B
| $26.6M | 0.01% |
383,930
-112,158
| -23% | -$7.77M |
|
505
Tarsus Pharmaceuticals
TARS
$2.43B
| $26.5M | 0.01% |
512,960
+500,478
| +4,010% | +$25.9M |
|
506
Tyra Biosciences
TYRA
$674M
| $26.3M | 0.01% |
2,693,237
+946,917
| +54% | +$9.25M |
|
507
Nutrien
NTR
$27.4B
| $26.3M | 0.01% |
523,874
+245,893
| +88% | +$12.3M |
|
508
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$5.44B
| $26.2M | 0.01% |
535,792
+169,751
| +46% | +$8.29M |
|
509
Black Hills Corp
BKH
$4.35B
| $26.2M | 0.01% |
435,719
+22,272
| +5% | +$1.34M |
|
510
PepsiCo
PEP
$200B
| $26.1M | 0.01% |
175,027
-177,490
| -50% | -$26.5M |
|
511
Robert Half
RHI
$3.77B
| $26.1M | 0.01% |
484,514
+20,035
| +4% | +$1.08M |
|
512
Tenable Holdings
TENB
$3.76B
| $26M | 0.01% |
742,777
+691,031
| +1,335% | +$24.1M |
|
513
Franklin FTSE Japan ETF
FLJP
$2.34B
| $25.9M | 0.01% |
875,116
+34,894
| +4% | +$1.03M |
|
514
OFG Bancorp
OFG
$1.99B
| $25.9M | 0.01% |
644,545
+9,728
| +2% | +$391K |
|
515
Columbia Banking Systems
COLB
$8.05B
| $25.6M | 0.01% |
1,034,471
-462,175
| -31% | -$11.4M |
|
516
Teradyne
TER
$19.1B
| $25.4M | 0.01% |
307,044
+48,958
| +19% | +$4.05M |
|
517
FB Financial Corp
FBK
$2.89B
| $25.4M | 0.01% |
538,802
-59,570
| -10% | -$2.8M |
|
518
MarketAxess Holdings
MKTX
$7.01B
| $25.1M | 0.01% |
115,676
+71,966
| +165% | +$15.6M |
|
519
Novanta
NOVT
$4.18B
| $25M | 0.01% |
193,997
+65,078
| +50% | +$8.4M |
|
520
Rocket Pharmaceuticals
RCKT
$354M
| $25M | 0.01% |
3,290,843
-713,196
| -18% | -$5.41M |
|
521
Rush Enterprises Class A
RUSHA
$4.53B
| $24.9M | 0.01% |
465,001
+135,974
| +41% | +$7.28M |
|
522
Chesapeake Utilities
CPK
$2.96B
| $24.8M | 0.01% |
194,091
+12,279
| +7% | +$1.57M |
|
523
Liquidia Corp
LQDA
$2.48B
| $24.7M | 0.01% |
1,639,351
+1,103,799
| +206% | +$16.7M |
|
524
Coca-Cola Consolidated
COKE
$10.5B
| $24.6M | 0.01% |
185,250
-30,920
| -14% | -$4.11M |
|
525
Stellantis
STLA
$26.2B
| $24.6M | 0.01% |
2,170,207
| – | – |
|